Neuromuscul. Disord. 2019 Dec 14
Emerging therapies for autoimmune myasthenia gravis: Towards treatment without corticosteroids.
Tannemaat MR, Verschuuren JJGM
Myasthenia gravis is an autoimmune disease characterized by dysfunction of the neuromuscular junction. Current treatment is based on lifestyle advice, ...
Read More
Source: PubMed
Neurologia 2020 Jan 28
Nivolumab: An «Immune storm» in a patient with history of myasthenia gravis.
Montalvo Moraleda T, Horga A, Galán Dávila L, Guerrero Sola A, Silva Hernández L
Read More
Source: PubMed
J Laparoendosc Adv Surg Tech A 2020 Jan 31
The Outcomes of Subxiphoid Thoracoscopic Versus Video-Assisted Thoracic Surgery for Thymic Diseases.
Xu H, Liu D, Li Y, Yang L, Wang F, Wang W, Zhang L
Objectives: The subxiphoid thoracoscopic approach may be an alternative to the lateral transthoracic approach in the treatment of thymic diseases. Thi ...
Read More
Source: PubMed
Neuromuscul. Disord. 2019 Nov 21
Paediatric myasthenia gravis: Prognostic factors for drug free remission.
Vecchio D, Ramdas S, Munot P, Pitt M, Beeson D, Knight R, Rodríguez Cruz P, Vincent A, Jayawant S, DeVile C, Buckley C, Hilton-Jones D, Robb S, Palace J
Our aim was to identify clinical outcomes, serological features and possible prognostic indicators of paediatric myasthenia gravis (MG). We collected ...
Read More
Source: PubMed
Front Immunol
Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis.
Gable KL, Guptill JT
Myasthenia gravis is an autoimmune disease in which immunoglobulin G (IgG) autoantibodies are formed against the nicotinic acetylcholine receptor (ACh ...
Read More
Source: PubMed
